Drug Side Effects
Search
EPILEPSIA PARTIALIS CONTINUA
EPILEPSIA PARTIALIS CONTINUA
was reported 42 times
EPILEPSIA PARTIALIS CONTINUA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]
8
0.0010
1
Sphingosine 1-phosphate Receptor Modulator [EPC]
4
0.0003
2
CD52-directed Cytolytic Antibody [EPC]
4
0.0002
3
Phenothiazine [EPC]
6
0.0002
4
Topoisomerase Inhibitor [EPC]
6
0.0001
5
Non-Standardized Plant Allergenic Extract [EPC]
1
0.0001
6
Anti-epileptic Agent [EPC]
11
0.0000
7
Mood Stabilizer [EPC]
8
0.0000
8
Integrin Receptor Antagonist [EPC]
3
0.0000
9
Benzodiazepine [EPC]
20
0.0000
10
Alkylating Drug [EPC]
7
0.0000
11
CD20-directed Cytolytic Antibody [EPC]
7
0.0000
12
Nucleoside Metabolic Inhibitor [EPC]
6
0.0000
13
CTLA-4-directed Blocking Antibody [EPC]
1
0.0000
14
Non-Standardized Food Allergenic Extract [EPC]
1
0.0000
15
Serotonin Reuptake Inhibitor [EPC]
1
0.0000
16
Kinase Inhibitor [EPC]
6
0.0000
17
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
0.0000
18
Aldosterone Antagonist [EPC]
1
0.0000
19
Azole Antifungal [EPC]
1
0.0000
20
Microtubule Inhibitor [EPC]
1
0.0000
21
Platinum-based Drug [EPC]
1
0.0000
22
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
23
Corticosteroid [EPC]
4
0.0000
24
Loop Diuretic [EPC]
1
0.0000
25
Platelet Aggregation Inhibitor [EPC]
1
0.0000
26
Proton Pump Inhibitor [EPC]
1
0.0000
27
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000